MabVax Therapeutics Holdings Inc (NASDAQ:MBVX)

2.09
Delayed Data
As of Feb 22
 +0.05 / +2.45%
Today’s Change
1.28
Today|||52-Week Range
10.71
-0.48%
Year-to-Date
No recent news for MabVax Therapeutics Holdings Inc.

Today’s Trading

Previous close2.04
Today’s open2.06
Day’s range2.05 - 2.20
Volume82,588
Average volume (3 months)119,902
Market cap$18.7M
Data as of 4:00pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)+94.58%
Earnings growth (this year)--
Earnings growth (next 5 years)+54.00%
Revenue growth (last year)-88.31%
P/E ratioNM
Price/Sales552.41
Price/Book4.93

Competitors

 Today’s
change
Today’s
% change
SSKNSTRATA Skin Sciences...-0.06-4.32%
EVFMEvofem Biosciences I...-0.24-3.14%
BSPMBiostar Pharmaceutic...-0.10-2.90%
ACERAcer Therapeutics In...-0.48-2.59%
Data as of 4:00pm ET, 02/22/2018

Financials

Last reporting dateAugust 14, 2017
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$148.1K
Annual profit (last year)-$17.7M
Net profit margin-11,928.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John David Hansen
CFO &
Principal Accounting Officer
Gregory P. Hanson
Corporate headquarters
San Diego, California

Forecasts